Authors/Disclosures
|
Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN
(University of Oxford)
|
Dr. De Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurology Academy. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. De Luca has received research support from NIHR, BRC (Oxford). The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from UK MS Society. The institution of Dr. De Luca has received research support from Oxford-Quinnipiac Partnership. The institution of Dr. De Luca has received research support from US Department of Defense. The institution of Dr. De Luca has received research support from Wellcome ISSF (Oxford). The institution of Dr. De Luca has received research support from Bristol Myers Squibb. The institution of Dr. De Luca has received research support from University of Oxford (John Fell Fund). The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). Dr. De Luca has a non-compensated relationship as a Editorial board member with MS Journal that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Vice-Chair of Grant Review Panel with UK MS Society that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Steering Group member with MS Academy that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Board of Directors with SEQUINS that is relevant to AAN interests or activities. |
|
Sreeram Ramagopalan
|
No disclosure on file |
|
|
No disclosure on file |
|
Lahiru Handunnetthi, MBBS
|
The institution of Dr. Handunnetthi has received research support from Janssen Pharmaceuticals. |
|
Basil Sharrack, MD, PhD, FAAN
(Department of Neuroscience)
|
Dr. Sharrack has nothing to disclose. |
|
|
No disclosure on file |
|
Sarah M. Orton, PhD
(Ebers Lab, University Of Oxford)
|
No disclosure on file |
|
Matthew R. Lincoln, MD, DPhil FRCPC
(St. Michael's Hospital)
|
No disclosure on file |
|
|
No disclosure on file |
|
Dessa Sadovnick, PhD
(VCHA-UBC Hospital)
|
No disclosure on file |
|
George C. Ebers, MD
|
No disclosure on file |
|
|
No disclosure on file |